Byung Ha Lee

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Recombinant Human

Bioinformatics Analysis

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Julie O'Neal, Matthew L Cooper, Julie K Ritchey, Susan W Gladney, Jessica Niswonger, L Sofia Gonzalez, Emily Street, Gabriel J Haas, Alun J Carter, Parmeshwar N Amayta, Feng Gao, Byung Ha Lee, Donghoon Choi, Melissa M Berrien-Elliott, Alice Yao Zhou, Todd A Fehniger, Michael P Rettig, John F DiPersio
Anti-myeloma efficacy of CAR-iNKT is enhanced with a long-acting IL-7, rhIL-7hyFc. Blood advances (2023)
Jingyu Xiang, Jessica M Devenport, Alun J Carter, Karl W Staser, Miriam Y Kim, Julie O'Neal, Julie K Ritchey, Michael P Rettig, Feng Gao, Garrett Rettig, Rolf Turk, Byung Ha Lee, Matthew L Cooper, John F Dipersio
An "off-the-shelf" CD2 universal CAR-T therapy for T-cell malignancies. Leukemia (2023)
Alexandra A Wolfarth, Swati Dhar, Jack B Goon, Ugonna I Ezeanya, Sara Ferrando-Martínez, Byung Ha Lee
Advancements of Common Gamma-Chain Family Cytokines in Cancer Immunotherapy. Immune network 22 (1) (2022)
Sojeong Kim, Sang Won Lee, June Young Koh, Donghoon Choi, Minkyu Heo, Jae-Yong Chung, Byung Ha Lee, Se Hwan Yang, Young Chul Sung, Howard Lee, Eui-Cheol Shin, Su-Hyung Park
A single administration of hIL-7-hyFc induces long-lasting T-cell expansion with maintained functions and TCR diversity. Blood advances (2022)
Miriam Y Kim, Reyka Jayasinghe, Jessica M Devenport, Julie K Ritchey, Michael P Rettig, Julie O'Neal, Karl W Staser, Krista M Kennerly, Alun J Carter, Feng Gao, Byung Ha Lee, Matthew L Cooper, John F Dipersio
A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity. Nature communications 13 (1) (2022)